Abacavir sulfate is a potent nucleoside reverse transcriptase inhibitor agent commonly prescribed in the management of human immunodeficiency virus (HIV) infection. It exerts its therapeutic effect by competitively inhibiting the function of the ADAPALENE 106685-40-9 viral reverse transcriptase enzyme, thereby hampering the conversion of HIV RNA to